Do all documents need to be signed in one color? Does the FDA not accept review by exception? What is real and what is a myth when it comes to FDA regulations for pharmaceutical manufacturing?
In our first episode of PEP talks, we’ll clear up some myths and misinterpretations of regulatory requirements with our expert guest Daniel R. Matlis, President and Founder of Axendia, Inc. You won’t want to miss this discussion as commonly held beliefs get busted.
Podden och tillhörande omslagsbild på den här sidan tillhör
Körber Pharma. Innehållet i podden är skapat av Körber Pharma och inte av,
eller tillsammans med, Poddtoppen.
